CompletedPhase 1NCT00000705

Safety and Effectiveness of Azidothymidine (AZT) in HIV-Positive Patients With Hemophilia

Studying Hemophilia A

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Principal Investigator
Richard C. Reichman, DDS, FICCMO, FACMS
Intervention
Zidovudine(drug)
Enrollment
24 target
Eligibility
12 years · All sexes
Timeline
1989

Study locations (2)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00000705 on ClinicalTrials.gov

Other trials for Hemophilia A

Additional recruiting or active studies for the same condition.

See all trials for Hemophilia A

← Back to all trials